Growing Demand in North America, Europe to Drive Drug Device Combination Market by Size, Share, Global Scope, Sales Revenue, Emerging Trends and Global Forecast to 2023


Market Highlights:
The global drug device combination market is expected to exhibit a strong 11.4% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The report presents a comprehensive picture of the global drug device combination market in terms of the historical growth figures of the market and the major drivers and restraints acting on the market and influencing its growth path.
The global drug device combination market is mainly driven by the increasing awareness about the efficacy of drug device combinations. Drug device combinations are used when either alone is not effective enough, or when a combination presents the best chance of recovery. Diseases such as tachycardia and coronary concerns show an improved recovery rate when treated with drug device combinations.

Access Full Report Details and TOC Exclusively @ https://www.marketresearchfuture.com/reports/drug-device-combination-market-6946

Competitive Analysis:

·         Zimmer Holding Inc
·         Wright Medical Group Inc
·         Stryker Corporation
·         St. Jude Medical Inc
·         Smith & Nephew plc
·         Covidien Ltd
·         Cook Critical Care Inc
·         C.R. Bard Inc
·         Boston Scientific Corporation
·         Biotronik
·         Biometrix Medical

Segmentation:

·         The global Drug Device Combination Market is segmented based on product, application, end use, and region.
·         By product, the global drug device combination market is segmented into catheters, advanced wound care products, and others.
·         By application, the market is segmented into coronary angioplasty, tachycardia management, non-cardiovascular treatments, peripheral arterial disease, bone treatments, antimicrobial applications, wound care, ophthalmic treatments, and others.
·         By end use, the global drug device combination market is segmented into hospitals and clinics, ambulatory centers, academic and research organizations, and others. Hospitals and clinics are likely to remain the leading end use segment over the forecast period due to their growing demand for drug device combinations.

Regional Analysis:

The Americas held the major share in the global drug device combination market in 2017 and are likely to emerge as the leading revenue generator over the forecast period till 2023, according to MRFR. The Americas drug device combination market is mainly driven by the growing awareness about the effectiveness of drug device combinations in North America, mainly the U.S. The growing drug device combination market in North America is mainly fed by the growing awareness about the efficacy of drug device combinations in the region. The highly advanced healthcare sector in North America has made note of the fact that some diseases, such as tachycardia and coronary issues, are best managed with a drug device combination. This is likely to remain the major driver for the drug device combination market in North America over the forecast period.
Rising consumption of junk food and increasing prevalence of sedentary lifestyles have driven the prevalence of cardiac issues in North America. The increasing healthcare expenditure in the region means that companies and major players are free to explore all possible options before settling on the best one. This has led to the creation of a strong research sector in the region, which has driven successful initiation of a number of drug therapies as well as devices into the healthcare sector in recent years. This is likely to remain a major driver for the North America drug device combination market over the forecast period.
Europe also holds a major place in the global drug device combination market and is likely to extend its position as one of the leading regional markets in the coming years thanks to the growing innovation in the healthcare industry in the region. Drug device combinations are likely to witness increasing demand in Europe in the coming years as the result of the increasing awareness of their efficacy in treating certain difficult conditions.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more